Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-01

Clinical Trial Update: Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a haploidentical transplant approach using TCRα/β depletion followed by CD45RA-depleted donor lymphocyte infusions for Sev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CD45RA-depleted donor lymphocyte infusions
  • TCRα/β depletion

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Severe Combined Immunodeficiency | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING